In order to identify the functional consequences of the PAX8–PRDM3 interaction on gene regulation, we performed PAX8 and PRDM3 chromatin immunoprecipitation sequencing (ChIP-seq) (with an antibody raised against PRDM3 PR domain) in NIH:OVCAR3 ovarian cancer cells. This evidence concerns the gene MECOM and ovarian cancer.